Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Luceco reports double-digit revenue growth

(Sharecast News) - Luceco reported double-digit first half revenue growth on Tuesday, supported by acquisitions and surging demand for electric vehicle charging products, with full-year expectations left unchanged. Group revenue rose 14.7% year-on-year to £125.7m in the six months ended 30 June, with like-for-like sales up 2%.

Growth was driven by a 93% jump in EV charging revenues, including a newly awarded supply agreement with Centrica-owned Hive, and a 14.1% contribution from acquisitions.

UK sales grew 3.6%, partly offset by weaker trading in some international markets.

Adjusted operating profit increased 9.5% to £13.8m, though the margin slipped to 11% as the group invested in energy transition opportunities and integration of recent acquisitions.

Adjusted profit before tax fell 3.6% to £10.8m, while statutory profit before tax declined 10.3% to £7.8m.

Adjusted earnings per share rose 3.5% to 5.9p, with statutory EPS down 2.2% to 4.4p.

Cash generation improved sharply, with adjusted free cash flow reaching £10.3m compared with an outflow of £1.7m a year earlier.

Bank net debt increased to £68m, representing 1.6 times EBITDA, within the group's target range.

The interim dividend was lifted 5.9% to 1.8p per share.

Luceco said it entered the second half with a strong order book and noted that revenue momentum had accelerated, with like-for-like growth improving from 0.6% in the first quarter to 3.2% in the second.

It also highlighted limited exposure to US-China tariffs, with only about £1m of first-half sales directly affected.

"I am pleased with the first half trading performance and these results reflect a robust performance built on Luceco's superior channel access, our proven ability to build strong positions in new categories by leveraging our product innovation capabilities and vertically integrated manufacturing facilities, and our ability to identify, execute and fund high quality acquisitions," said chief executive John Hornby.

"We are optimistic that confidence in our sectors of the economy will recover further in the second half of 2025.

"The group's trading remains in line with expectations for further growth in the year ending December 2025."

At 0959 BST, shares in Luceco were up 6.1% at 125.62p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.